Lung cancer - docetaxel, paclitaxel, gemcitabine and vinorelbine (updated by and incorporated into CG24 Lung cancer)
Docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer
Summary
This guidance has been replaced by Lung cancer - the diagnosis and treatment of lung cancer (CG24)
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA26
Issued: June 2001
How this guidance was produced